Timothy Barrett, CEO of Biomedical Systems of St. Louis, MO / Brussels, Belgium, announced today that the company has surpassed the $100 million dollar mark in business backlog. Biomedical Systems’ backlog is totaled across the six divisions that make up the company; Pharmaceutical Services, Cardiology Services, Imaging Services, Women’s Health Services, Wound Care Products and Veterinary Services. “This is a significant milestone in the growth of the company and growth in employment opportunities. Companies get to this level with two key components, a blue chip roster of clients and a professional, dedicated staff of teammates. We are fortunate enough to have an abundance of both,” said Mr. Barrett. 

Use of centralized imaging in clinical trials to determine efficacy offers Sponsors enormous possibilities in terms of study design and data acquisition. Learn more about the efforts to standardize certain prossesses to improve imaging clinical trials.